Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis

Abstract

The forkhead family members of transcription factors (FoxOs) are expected to be potential cancer-related drug targets and thus are being extremely studied recently. In the present study, FoxO3a, one major member of this family, was identified to be down-regulated in colorectal cancer through micro-array analysis, which was confirmed by RT-PCR and Western blot in 28 patients. Moreover, immunohistochemistry (IHC) showed that the expression levels of FoxO3a were remarkably reduced in 99 cases of primary colorectal cancer, liver metastasis, and even in metaplastic colorectal tissue. IHC also revealed an exclusion of FoxO3a from the nucleus of most cells of tumor-associated tissues. Silencing FoxO3a by siRNA led to elevation of G2-M phase cells. We conclude that the downregulation of FoxO3a may greatly contribute to tumor development, and thus FoxO3a may represent a novel therapeutic target in colorectal cancer.

Keywords

FoxO3a / colorectal cancer / transcription factor / cell cycle arrest / target therapy

References

[1] EilsteinD, HedelinG, SchafferP. Incidence of colorectal cancer in Bas-Rhin, trend and prediction in 2009. Bull Cancer, 2000, 87(7–8): 595-599

[2] GradyWM, MarkowitzSD. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet, 2002, 3: 101-128

[3] AcciliD, ArdenKC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell, 2004, 117(4): 421-426

[4] TicchioniM, EssafiM, JeandelPY, et al.. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene, 2007, 26: 7081-7091

[5] KauTR, SchroederF, RamaswamyS, et al.. A chemical genetic screen identifies Inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell, 2003, 4(6): 463-476

[6] RadetzkiS, KohneCH, VonHC, et al.. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overex-pressing breast cancer cell lines. Oncogene, 2002, 21(2): 227-238

[7] ChenQ, ChaiYC, MazumderS, et al.. The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ, 2003, 10: 323-334

[8] SantosNR, TorensmaR, VriesT, et al.. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res, 2000, 60: 1654-1662

[9] WuJ, FengY, XieD, et al.. Unscheduled CDK1 activity in G1 phase of the cell cycle triggers apoptosis in X-irradiated lymphocytic leukemia cells. Cell Mol Life Sci, 2006, 63: 2538-2545

[10] ArdenKC. FoxO: linking new signaling pathways. Mol Cell, 2004, 14(4): 416-418

[11] HeideLP, HoekmanMF, SmidtMP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J, 2004, 380(2): 297-309

[12] KopsGJ, MedemaRH, GlassfordJ, et al.. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol, 2002, 22(7): 2025-2036

[13] ScheijenB, NgoHT, KangH, et al.. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins. Oncogene, 2004, 23: 3338-3349

[14] YuanM, KonstantopoulosN, LeeJ, et al.. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science, 2001, 293(5535): 1673-1677

[15] HuMC, LeeDF, XiaW, et al.. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell, 2004, 117(4): 225-237

[16] GuTL, TothovaZ, ScheijenB, et al.. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood, 2004, 103(12): 4622-4629

[17] BelguiseK, SonensheinGE. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. J Clin Invest, 2007, 117(12): 4009-4021

[18] LynchRL, KonicekBW, McNultyAM, et al.. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol Cancer Res, 2005, 3(163): 163-169

[19] TranH, BrunetA, GrenierJM, et al.. DNA repair pathway stimulated by the Forkhead transcription factor FOXO3a through the Gadd45 protein. Science, 2002, 296(5567): 530-534

[20] AlvarezB, MartinezA, BurgeringBM, et al.. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature, 2001, 413: 744-747